Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250)

South Korea · Delayed Price · Currency is KRW

825,000

+68,000 (8.98%)

At close: Feb 27, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Pharmaceuticals	210.92B	192.67B	177.34B	167.27B	166.86B
Pharmaceuticals Growth	9.47%	8.65%	6.01%	0.25%	-10.58%
Total	210.92B	192.67B	177.34B	167.27B	166.86B
Total Growth	9.47%	8.65%	6.01%	0.25%	-10.58%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
South Korea	198.78B	183.18B	166.84B	161.19B	158.29B
South Korea Growth	8.52%	9.79%	3.51%	1.83%	-5.91%
Overseas	12.14B	9.49B	10.50B	5.84B	8.33B
Overseas Growth	27.97%	-9.59%	79.59%	-29.87%	-54.64%
Total	210.92B	192.67B	177.34B	167.03B	166.62B
Total Growth	9.47%	8.65%	6.17%	0.25%	-10.71%

Source: S&P Global Market Intelligence.